Inhaled Nitric Oxide for Microvascular Dysfunction in Traumatic Brain Injury
Key facts
- Who runs it
- University of Pennsylvania
- Where
- Philadelphia, United StatesSee the site
- Trial code
- Status
- Enrolling by invitation
- Phase
- Phase 2
- People taking part
- 38 people, planned
- Started
- 6 Apr 2025
- Expected to end
- 28 Mar 2028
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- inhaled nitric oxide
- Record updated
- 17 June 2026
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Aged 18-75 (inclusive)
- GCS 9-12 or GCS 13-15 with an abnormal imaging scan
- Radiologic findings indicative of primarily diffuse TBI
Who cannot take part
- Severe cardiac dysfunction (e.g. elevation of pulmonary edema on chest xray, large elevation of cardiac enzymes)
- Pre-existing disabling psychiatric or neurological disorders such as cortical stroke, brain tumor, disabling multiple sclerosis, dementia, and severe TBI
- Known intracranial vessel disease
- Acute Respiratory Distress Syndrome (ARDS) or pre-existing pulmonary hypertension
- Chronic Kidney Disease (Glomerular Filtration Rate <60mL/min/1.73m2)
- Respiratory Infection
- Possible drug interactions (nitric oxide donors: prilocaine, sodium nitroprusside, nitroglycerin)
- Large focal injury (subdural hematoma, epidural hematoma, intraparenchymal hematoma, >30mL aggregate volume)
- Need for immediate neurosurgical intervention
- Cardiopulmonary resuscitation or cardioversion at admission
- Prisoners, patients in police custody, pregnant women
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Where in United States
- Penn Presbyterian Medical CenterPhiladelphia, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
Traumatic brain injury (TBI) causes acute deficits in cerebral perfusion which may lead to secondary injury and worse outcomes. Inhaled nitric oxide (iNO) is a vasodilator that increases cerebral blood flow and is clinically used for hypoxic respiratory failure in neonates and adults. The investigators will perform a randomized controlled trial of iNO treatment in TBI patients acutely after injury. The investigators will then assess perfusion changes with optic neuromonitoring, blood biomarkers, and 6 month clinical outcomes.
The 2 groups in the trial
- Group iNOTreatment being tested
Subjects will receive iNO for 4 hours, followed by standard respiratory support (SRS) for 4 hours. This pattern will be reversed the next day (SRS then iNO). on the following day, the pattern will be reversed back to iNO for 4 hours and SRS for 4 hrs.
Treatment: inhaled nitric oxide
- Group SRSSham treatment, for comparison
Subjects will receive standard respiratory support (SRS) for 8 hours.
Treatment: inhaled nitric oxide
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT05616910, who can take part
- Record updated
- 17 June 2026